Open access
42
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention
Janet Pope1 Division of Rheumatology, University of Western Ontario, London, Ontario, Canada
https://orcid.org/0000-0003-1479-5302View further author information
Axel Finckh2 Division of Rheumatology, University Hospital of Geneva, Geneva, Switzerland
https://orcid.org/0000-0002-1210-4347View further author information
Lucia Silva-Fernández3 Rheumatology Department, A Coruña University Hospital Complex, A Coruña, Spain
https://orcid.org/0000-0002-5159-6575View further author information
Peter Mandl4 Division of Rheumatology, Medical University of Vienna, Vienna, AustriaView further author information
, Haiyun Fan5 Pfizer Inc, Collegeville, PA, USAView further author information
, Jose L Rivas6 Pfizer SLU, Madrid, Spain
https://orcid.org/0009-0004-6736-3962View further author information
Monica Valderrama6 Pfizer SLU, Madrid, SpainView further author information
& Maria Montoro6 Pfizer SLU, Madrid, SpainCorrespondence[email protected]
View further author information
show allView further author information
Pages 115-126
|
Received 18 Nov 2023, Accepted 28 May 2024, Published online: 12 Jun 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.